Cytomegalovirus Viremia in Lung Transplant Recipients Receiving Ganciclovir and Immune Globulin

This publication has 30 references indexed in Scilit:

• Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Cytomegalovirus Antibody-Positive Renal Transplant Recipients
  Annals of Internal Medicine, 1995
• Prophylaxis of Primary Cytomegalovirus Disease in Renal Transplant Recipients
  Archives of Surgery, 1994
• High-Dose Acyclovir Compared with Short-Course Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Liver Transplant Recipients
  Annals of Internal Medicine, 1994
• A PROSPECTIVE RANDOMIZED STUDY OF ACYCLOVIR VERSUS GANCICLOVIR PLUS HUMAN IMMUNE GLOBULIN PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION AFTER SOLID ORGAN TRANSPLANTATION1,2
  Transplantation, 1994
• Cytomegalovirus Immune Globulin Prophylaxis in Liver Transplantation
  Annals of Internal Medicine, 1993
• A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation
  New England Journal of Medicine, 1992
• A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants
  New England Journal of Medicine, 1991
• Impact of Cytomegalovirus Infection on Organ Transplant Recipients
  Clinical Infectious Diseases, 1990
• A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts
  New England Journal of Medicine, 1989
• Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant Recipients
  New England Journal of Medicine, 1987